Sun Pharmaceutical Industries Share Price Target Tomorrow 2024 To 2030

Sun Pharmaceutical Industries Ltd is one of India’s largest and most respected pharmaceutical companies. Founded in 1983, it specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic medicines, branded formulations, and over-the-counter drugs. The company focuses on high-quality, affordable medications, helping to improve healthcare for people worldwide. Sun Pharmaceutical Industries Share Price on NSE as of 28 October 2024 is 1,902.00 INR. Here will provide you more details on Sun Pharmaceutical Industries Share Price Target 2024, 2025, 2026 to 2030.

Sun Pharmaceutical Industries Ltd: Market Overview

• Open Price: ₹1,863.20
• High Price: ₹1,916.00
• Low Price: ₹1,835.00
• Previous Close: ₹1,860.40
• Volume: 2,445,724
• Value (Lacs): ₹46,539.68
• VWAP: ₹1,891.11
• UC Limit: ₹2,046.40
• LC Limit: ₹1,674.40
• P/E ratio: 43.91
• Div yield: 0.71%
• 52-wk high: ₹1,960.35
• 52-wk low: ₹1,068.35
• Mkt cap: ₹4.57LCr

Sun Pharmaceutical Industries Share Price Chart

Sun Pharmaceutical Industries Share Price Target Tomorrow 2024 To 2030

Sun Pharmaceutical Industries Share Price Target 2024

Sun Pharmaceutical Industries share price target 2024 Expected target could be ₹1970. Here are three key risks and challenges that could impact the share price of Sun Pharmaceutical Industries Ltd for 2024:

• Regulatory Challenges: The pharmaceutical industry is heavily regulated, and any changes in regulations or compliance issues can significantly affect operations. If Sun Pharma faces regulatory scrutiny or delays in approvals for new drugs, it could hinder product launches and negatively impact revenue.
• Intense Competition: The global pharmaceutical market is highly competitive, with numerous players vying for market share. Sun Pharma faces competition from both established companies and emerging players, particularly in the generic drug segment. Increased competition can lead to pricing pressures and reduced profit margins, affecting the company’s overall financial performance.

• Dependence on Key Products: Sun Pharma’s revenue is heavily reliant on a few key products and therapeutic areas. Any decline in sales due to patent expirations, increased competition, or changes in market demand for these products could significantly impact the company’s revenue and share price. Diversifying the product portfolio and reducing reliance on a limited number of products will be crucial for sustained growth.

Sun Pharmaceutical Industries Share Price Target 2025

Sun Pharmaceutical Industries share price target 2025 Expected target could be ₹2640. Here are three key risks and challenges that could impact the share price of Sun Pharmaceutical Industries Ltd for 2025:

• Market Volatility: Economic uncertainties and market volatility can adversely affect investor sentiment and stock prices. Factors such as fluctuations in currency exchange rates, changes in interest rates, or global economic downturns could lead to unpredictable performance, impacting Sun Pharma’s share price in 2025.
• R&D Pipeline Execution: Sun Pharma invests heavily in research and development to introduce new and innovative products. However, if the company fails to advance its R&D pipeline successfully or encounters delays in clinical trials, it may miss out on potential revenue streams. Moreover, if newly launched products do not perform as expected, it could lead to a decline in investor confidence and affect the share price.

• Supply Chain Disruptions: The pharmaceutical industry relies on a complex supply chain for raw materials, production, and distribution. Any disruptions—such as natural disasters, geopolitical tensions, or logistical challenges—could hinder production capabilities and affect the timely delivery of products. These disruptions may lead to increased costs and lower revenues, thereby impacting the overall share price in 2025.

Sun Pharmaceutical Industries Share Price Target 2030

Sun Pharmaceutical Industries share price target 2030 Expected target could be ₹5180. Here are three key risks and challenges that could impact the share price of Sun Pharmaceutical Industries Ltd for 2030:

• Evolving Regulatory Landscape: The pharmaceutical industry is subject to stringent regulations that can change over time. If new regulations are introduced or existing ones become more stringent, Sun Pharma may face increased compliance costs and delays in product approvals. These challenges can hinder the company’s ability to bring new products to market, affecting future revenue and share price.
• Technological Advancements and Disruption: The rapid pace of technological innovation in healthcare, including the rise of personalized medicine and digital health solutions, could pose challenges for traditional pharmaceutical companies like Sun Pharma. If the company fails to adapt to new technologies or innovate effectively, it may lose competitive advantages, leading to potential declines in market share and profitability.

• Global Health Trends and Demands: The healthcare landscape is constantly evolving, influenced by factors such as population aging, rising chronic diseases, and shifts in consumer preferences. Sun Pharma needs to anticipate and respond to these changes effectively. Failure to align its product offerings with market demands or to invest in therapeutic areas with high growth potential could limit the company’s growth prospects and negatively impact its share price by 2030.

Shareholding Pattern For Sun Pharmaceutical Industries Ltd

• Promoters: 54.48%
• FII: 18.02%
• Mutual Funds: 12.11%
• Retail and Others: 8.89%
• DII: 6.49%

FOR MORE DETAIL FOLLOW THE OFFICIAL WEBSITE: http://www.sunpharma.com/

Sun Pharmaceutical Industries Ltd Financials

Read Also:- Titan Share Price Target Tomorrow 2024 To 2030- Market Overview, Income Statement